Translational Life Sciences

Translational Life Sciences is a private Vancouver-based drug discovery biotech focused on restricted-substance and psychedelic-derived therapeutics for clinical applications. The company has built capabilities in high-throughput functional cell-based screening, animal testing, botanical compound profiling, and brain receptor profiling to evaluate mushroom- and psilocybin-related compounds. Its work has centered on discovering and developing natural product-based candidates for mental health and related indications, with additional stated interest in concussion, eating disorders, obesity, and diabetes. Translational Life Sciences has collaborated with external partners on psychedelic compound evaluation and has operated R&D labs associated with the University of British Columbia. Publicly available information suggests the company remains at a preclinical platform and discovery stage rather than an advanced clinical-stage developer.